Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries
Thalis Christophides, Alice C. Wei(Université Paris Cité), Thilo Hackert(Universität Hamburg), Martín de Santibañes, Orlando Jorge Martins Torres, Christian Diaz, Aditya Borakati, Ajith K. Siriwardena(Manchester Royal Infirmary), Marc G. Besselink(Amsterdam Neuroscience), Isabella Frigerio(Casa di Cura Villa Garda), Marinos Zachiotis, Atsushi Oba(Tokyo Medical and Dental University), Andreas A. Schnitzbauer(American Institute of Biological Sciences), Giuseppe Fusai(The Royal Free Hospital), Shailesh V. Shrikhande(Homi Bhabha National Institute), Nikolaos Gouvas, Christian E. Oberkofler(Klinik Hirslanden), Ioannis Passas(St Savas Hospital), Dimitri Aristotle Raptis(King Faisal Specialist Hospital & Research Centre), Nikolay Belev, Marco Del Chiaro(University of Colorado Hospital), Deniz Balcı, Kevin C. Conlon(Trinity College Dublin), Fiammetta Soggiu, Ewen M. Harrison(NHS Lothian), Martin Smith(King Faisal Specialist Hospital & Research Centre), Christopher L. Wolfgang(Johns Hopkins University), Reena Ravikumar, Claudio Bassi(University of Verona), Christos Dervenis(Agia Olga Hospital), Brian Davidson(King Faisal Specialist Hospital & Research Centre), M.A. Hilal(King Faisal Specialist Hospital & Research Centre), Salah Eddine Kacimi, Maher Hendi, Patricia Sánchez‐Velázquez(King Faisal Specialist Hospital & Research Centre), Kamel Bentabak
Cited by 52
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k